So for supportive care we can consider transfusions for those patients that have anemia and do not have any available treatments. However, for transfusions, we must consider all available treatments that can avoid transfusions.
As far as infections are concerned, there’s a lot of research regarding whether or not to use antifungals and prophylaxis for certain hematological malignancies before, during chemotherapy, after chemotherapy, and also the broad-spectrum antimicrobials...
So for supportive care we can consider transfusions for those patients that have anemia and do not have any available treatments. However, for transfusions, we must consider all available treatments that can avoid transfusions.
As far as infections are concerned, there’s a lot of research regarding whether or not to use antifungals and prophylaxis for certain hematological malignancies before, during chemotherapy, after chemotherapy, and also the broad-spectrum antimicrobials. And there’s a lot of investigation on gut environment and how this impacts patient outcomes in terms of chemotherapy, infections, and overall results in the treatment of the malignancies. So, there’s a lot of research; we still don’t have definite answers, but I think we’re on our way to having novel strategies to better support patients.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
